U.S. Loses Measles Elimination Status Following Vaccination Decline

The United States has officially lost its measles elimination status, a designation it had maintained since 2000. The Pan American Health Organization (PAHO) announced this week that the virus is now classified as endemic within the country, signaling that measles is circulating continuously rather than existing only as sporadic, imported cases.
Under international health standards, a nation is recognized as having achieved elimination status only when it has maintained an absence of continuous transmission of the same measles virus genotype and lineage for at least 12 consecutive months. The loss of this status comes after the U.S. experienced a notable rise in infections over the last two years. This surge has resulted in 11 deaths reported during the current year across New York, Pennsylvania, and Wisconsin.
Dr. Jeffrey Kahn, chief of infectious diseases at Children’s Health in Texas and a professor at UT Southwestern Medical Center, described the loss of status as a symbolic turning point. He noted that the virus itself and the available vaccines have remained unchanged for decades. The core issue, according to Kahn, is a decrease in vaccination coverage that has allowed the virus to gain a foothold in under-vaccinated communities.
“It reflects the fact that we had measles under control for a quarter of a century, and now we’ve lost control of the virus,” Kahn said. “What has changed is that we have lower vaccination rates, and now the virus has gotten into the country and is spreading through communities that have low vaccination rates.”
To regain the status, public health experts emphasize the necessity of boosting population-level immunity. Kahn stated that the country likely requires at least 95% of the population to be immunized to achieve herd immunity, a threshold at which the majority of a community is protected, thereby making it significantly more difficult for the virus to reach vulnerable individuals.
Beyond vaccination efforts, Dr. Peter Chin-Hong, an infectious diseases specialist and associate dean for regional campuses at the University of California, San Francisco, highlighted the need for improved diagnostic infrastructure. Current laboratory testing can take up to two weeks to return results, a delay that hampers the ability to isolate patients effectively and contain outbreaks. He suggested that integrating wastewater surveillance systems and expanding access to rapid, point-of-care diagnostic tools—similar to technologies deployed during the COVID-19 pandemic—could significantly enhance early detection.
While the current situation presents a serious public health challenge, precedent exists for recovery. Both Venezuela and Brazil lost their elimination status following outbreaks in 2018 and 2019, respectively, yet both nations implemented necessary control measures and successfully regained their status by 2024. PAHO indicated that the U.S. is currently working to implement similar strategies to strengthen vaccination coverage, surveillance, and outbreak response protocols.